Gimv-Venture Capital Biotech is a private equity general partner firm.
Gimv, together with other shareholders, has sold its controlling stake in VCST to BMT Group.
JenaValve Technology, a biotechnology company, has raised $26.5m in Series C funding co-led by RMM and Valiance.
Gimv has made an impressive 4.6x return by selling its stake in Prosensa, a genetic disorder treatment company, to BioMarin.
Read more news concerning Gimv-Venture Capital Biotech
A sampling of Gimv-Venture Capital Biotech portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?